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Summary 
The ability of the B cell antigen receptors (BCRs) to 
enhance MHC class II-restricted antigen presentation 
was ascribed to mlg-associated Iga/lgg heterodimers. 
The relative role of Iga and lgf3 subunits in antigen 
presentation was investigated by fusing their cyto- 
plasmic tails to the extracellular and transmembrane 
domains of Fc receptors. Iga and lgf3 chimera mediate 
antigen internalization and increase the efficiency of 
antigen presentation, but they drive antigens to differ- 
ent endosomal compartments. Furthermore, antigens 
internalized by either chimera are degraded and pre- 
sented with different kinetics. The cytoplasmic tail 
of Iga targets antigen towards a major population of 
newly synthesized MHC class II located in class II-rich 
compartments. In contrast, lgf3 targets antigen to- 
wards a minor population of recycling MHC class II 
molecules, located in transferrin receptor-containing 
endosomes. Altogether, our data indicate that the 
composition of BCR could be therefore an important 
way to modulate the immune response. 
Introduction 
Internalization and processing of exogenous antigens is 
a crucial step to elicit T lymphocyte stimulation during im- 
mune responses. Internalized antigens are transported to 
endocytic compartments where they undergo proteolytic 
degradation (Cresswell, 1994; Germain, 1994). Antigen- 
derived peptides associated to major histocompatibility 
complex (MHC) class II molecules are then transported 
to the cell surface to activate specific T cells. The uptake 
of free antigen may occur by fluid phase endocytosis or 
by receptor-mediated internalization. Depending on the 
antigen-presenting cell, different surface receptors are 
used for antigen capture (Lanzavecchia, 1990). B lympho- 
cytes express clonally distributed membrane immuno- 
globulins (mlg) receptors that specifically bind antigen, 
while macrophages express receptors for the Fc portion 
of IgG (FcyR), which bind antigen-containing immune 
complexes. In both cases, antigen-antibody complexes 
are internalized and thus facilitate MHC class II antigen 
presentation (Lichtman et al., 1987; Snider and Segal, 
1987; Casten et al. 1988; Lanzavecchia, 1990; Manta et 
al., 1991; Amigorena et al., 1992a, 1992b). 
Processed antigens meet MHC class II molecules that 
have reached endocytic organelles after a complex series 
of transport steps. Class II molecules are synthesized as 
trimers of invariant chains (Ii) associated to three a8 het- 
erodimers. From the Golgi apparatus, class II are targeted 
to the endosomal pathway, where the Ii chain is degraded, 
allowing the a8 dimers to bind peptides and to reach the 
cell surface (Cresswell, 1994). Moreover, ap dimers may 
reenter the endosomal pathway from the cell surface by 
a rapid internalization-recycling shuttling (Reid and Watts, 
1990; Salamero et al., 1990). Both cell surface and newly 
synthesized MHC class II molecules may reach endocytic 
compartments, although only newly synthesized class II 
were found to bind efficiently peptides generated within 
the endocytic pathway of human B lymphoblasts (David- 
son et al., 1991). Early and late endosomes, as well as 
lysosomes, were proposed as possible sites of antigen 
processing and peptide association with MHC class II mol- 
ecules (Germain, 1994). Morphological studies on human 
B lymphoblasts found MHC class II in a population of intra- 
cellular vesicles, distinct from conventional endosomes 
and lysosomes (Pieters et al., 1991). Cell fractionation of 
B lymphocytes allowed purification and identification of 
this intracellular compartment as a multivesicular body 
where newly synthesized MHC class II molecules tran- 
siently accumulate and bind peptides derived from inter- 
nalized antigens (Amigorena et al., 1994; Qiu et al., 1994; 
West et al., 1994). These vesicles were proposed to repre- 
sent specialized antigen-processing compartments. 
B lymphocytes express specific antigen receptors (BCRs) 
that may transport antigens to MHC class II-containing 
compartments (West et al., 1994). BCRs are molecular 
complexescomposed of binding subunits, the mlg, nonco- 
valently associated with Iga and lg8 disulfide-linked het- 
erodimers (Campbell and Cambier, 1990; Hombach et al., 
1990). As in the case of the type Ill Fc receptor-associated 
y chains, the association of lgallg8 sheath to mlg deter- 
mines the efficiency of antigen presentation (Amigorena 
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et al., 1992b; Pate1 and Neuberger, 1993; Shaw et al., 
1990). To investigate the role of the cytoplasmic tail of Iga 
and lgf3 in antigen processing and targeting, we expressed, 
in a B lymphoma cell line, chimerical molecules containing 
the extracellular and the transmembrane domains of the 
type II receptor for the Fc portion of IgG and the cyto- 
plasmic tails of either lga or lgf3. The ability of these FcR- 
based chimeras to bind IgG-complexed antigens allowed 
us to show that the cytoplasmic tails of both Iga and lgp 
mediate efficient ligand internalization via clathrin-coated 
pits and enhance antigen presentation. However, only the 
cytoplasmic tail of Iga contains sorting information ac- 
counting for the ability of the BCR to deliver antigens to 
the intracellular sites of MHC class II accumulation and to 
use newly synthesized MHC class II molecules for antigen 
presentation. In contrast, Igj3-driven antigen presentation 
involved preexisting MHC class II molecules. Moreover, 
lgp chimeras targeted antigen towards early endosomal 
compartments. We conclude that Iga and lgj3 chimeras 
transport antigen towards distinct subcompartmentsof the 
endocytic pathway leading to different pathways of antigen 
processing. 
Results 
Iga and lgp form heterodimers noncovalently associated 
to mlg and they allow specific uptake of antigen (Shaw et 
al., 1990; Pate1 and Neuberger, 1993). The relative partici- 
pation of these two subunits in antigen internalization and 
the subsequent presentation of antigen-derived peptides 
by class II was investigated by constructing chimerical 
proteins. The extracellular and transmembrane domains 
of mouse FcyRll alone (FcR-IC-) (Amigorenaet al., 1992a) 
or fused to the cytoplasmic tail of either Iga or lgp (FcR- 
Iga, FcR-lgp) (Choquet et al., 1994) (Figure 1A) were ex- 
pressed in the B cell line II-Al.6, which bears mlg and 
MHC class II molecules at the cell surface but does not 
express FcyR genes (Jones et al., 1986). The transfectant 
cell lines express similar levels of the different chimeras 
(Figure 1 B). 
The Cytoplasmic Domains of Iga and Igj.3 Mediate 
Efficient Ligand Internalization 
The ability of the cytoplasmic domains of Iga and lg8 to 
mediate ligand internalization was first analyzed by mea- 
suring the uptake of the rat anti-mouse FcR monoclonal 
antibody (MAb), 2.4G2 (Unkeless, 1979). Transfectant 
cells were incubated at 0°C with I*?-2.4G2, washed, and 
the antibodies were then cross-linked with F(ab’)* frag- 
ments of a mouse anti-rat antiserum before incubation 
at 37% for different times. The internalized fraction was 
determined after acid elution of antibodies remaining at 
the cell surface. In these conditions, the cytoplamic do- 
mains of Iga and lgj3 mediate the efficient internalization 
of cross-linked chimeras, since 60% of iodinated antibody 
is internalized after 5 min, whereas tail-minus FcR (FcR- 
IC-) remain at the cell surface even after 15 min of incuba- 
tion at 37OC (Figure 2A). When immune complexes were 
used as ligands of chimeras, similar results were obtained 
(data not shown). Therefore, cytoplasmic tails of Iga and 
FctVlg-p FcwIC- 
Figure 1. Fusion Proteins between FcR and the Cytoplasmic Tails of 
Iga and lgf3 
Schematic representation of B cell antigen receptor, of FcFt-lga, FcR- 
Igf3 chimeras, and tail-minus FcR. 
(A) The cytoplasmic domains of Iga (61 aa) and Igf3 (45 aa) were added 
to the extracellular and transmembrane domains of cDNA encoding 
mouse FqRll (FcR). For FcR-IC, a stop codon was introduced after 
the first amino acid starting the cytoplasmic tail of mouse type II FcR 
for IgG. 
(9) Surface expression of the fusion proteins. FcR expression was 
detected by indirect immunofluorescence with the rat anti-FcR anti- 
body 2.4G2 and fluorescein-conjugated mouse anti-rat antibody. All 
the cells expressed similar levels of I-A molecules detected by specific 
MAb MKD6 (data not shown). 
lgj3 contain all the information required for the efficient 
uptake of antigen in B lymphocytes. 
Before their delivery to the endosomal pathway, endocy- 
tosed membrane proteins are first segregated from resi- 
dent plasma membrane proteins and concentrated in a 
specialized membrane area, known as clathrin-coated pits 
(Trowbridge et al., 1994). The tranfectant cells were incu- 
bated as above with colloidal gold-conjugated 2.462 anti- 
bodies then F(ab’)n fragments of mouse anti-rat antiserum. 
As illustrated in Figure 28, we established, by electron 
microscopy, that both cross-linked FcR chimeras were lo- 
cated in clathrin-coated pits during internalization. After 
10 min of incubation at 37%, gold-labeled antibodies were 
also found in endosomal compartments for both trans- 
fectants. The same results were obtained with immune 
complexes constituted of colloidal gold-labeled dinitrophe- 
nyl-bovine serum albumin (DNP-BSA) complexed with 
the immunoglobulin G (IgG) fraction of a rabbit anti-DNP 
antiserum (data not shown). Therefore, the cytoplasmic 
domains of Iga and lgj3 are sufficient for clathrin-depen- 
dent endocytosis of cross-linked receptors. 
Efficient Presentation of Iga- and 
Igp-Targeted Antigen 
After internalization, endocytosed antigens are degraded 
and derived peptides are presented to T cells by MHC 
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Figure 2. The Cytoplasmic Tails of Iga and 
clgp Mediate Efficient Ligand Internalization 
The internalization of chimeras was assessed 
after binding of anti-FcR MAb 2.462. 
(A) Cells expressing FcR-lga, FcR-Ig3, and 
FcR-IC- moleculeswere incubated at 4OC with 
iodinated 2.462 and mouse anti-rat antiserum, 
then internalization was started by transferring 
the cells at 37V for different times. The inter- 
nalized fraction was measured after acid elu- 
tion of iodinated antibodies remaining at the 
cell surface. 
(B) Micrographsof FcR-lga and FcR-Ig3 local- 
ization in clathrin-coated area of the plasma 
membranes. FcR-lgu and FcR-Igb expressing 
cells were incubated with colloidal gold- 
coupled (5 nm) 2.4G2 MAb at 4% as above 
and then transferred at 37°C for 10 min. After 
fixation the cells were processed for electron 
microscopy. Scale bars, 0.2 pm. Arrowhead in- 
dicates coated vesicles. 
class II molecules (Cresswell, 1994; Germain, 1994). The 
ability of Iga or lg8 to mediate efficient internalization sug- 
gests that they may enhance antigen presentation. For 
this purpose, we used the ability of F&based chimeras 
to bind IgG-complexed antigens specifically (Amigorena 
et al., 1992a, 1992b). The repressor of the h phage was 
used as antigen and immune complexes were formed by 
adding two IgGl anti-i repressor antibodies, which target 
the antigen to FcR chimeras (Amigorena et al., 1992a, 
1992b). The presentation of 12-24 and 46-64 peptides 
from h repressor was detected using T cell hybridomas 
that recognize these peptides in association with 1-A”. 
Cells expressing FcR-lga chimeras, FcR-Ig8 chimeras, 
or tail-minus FcR (FcR-IC-) were incubated for 24 hr in 
the presence of both increasing doses of h repressor pre- 
complexed or not to IgG and specific T hybridoma cells. 
Complexed antigen was presented at doses at least 1 OOO- 
fold lower than free antigen with similar dose effects for 
both peptides on both FcR-lga or FcR-Ig6 expressing 
cells (Figure 3). These two cell lines presented the 12-24 
peptide, but not the 46-64 peptide, at high concentrations 
of uncomplexed ?, repressor (lo-30 pg/ml) and FcR-IC- 
cells did not present 46-64 peptides, even when h repres- 
sor was complexed to specific IgG (Figure 3). These re- 
sults indicate that the presentation of 46-64 peptide was 
strictly dependent on antigen internalization by FcR-lga 
or FcR-Igf3 chimeras. The cells have similar presenting 
abilities, since, in control experiments, we have observed 
that the three presenting ceils activated specific T cell 
hybridoma with similar concentrations of 46-64 or 12-24 
peptides, directly added to fixed cells (data not shown). 
The processing ability of antigen-presenting cells were not 
modified by chimera engagement, since the addition of 
irrelevant immune complexes (DNP-BSA complexed with 
anti-DNP rabbit IgG) to high concentrations of free h re- 
pressor neither induced presentation of 46-64 peptide nor 
modified the level of I-A expression on the cell surface of 
the three presenting cell lines (data not shown). In addition, 
the cells did not express 87 molecules and their expres- 
sion was not induced by incubation with immune com- 
plexes (data not shown). Therefore, the cytoplasmic do- 
mains of both Iga and lgf3 allow antigen presentation by 
MHC class II molecules. 
Kinetics of Presentation and Processing of Antigen 
Internalized through Iga and lgfi Chimeras 
Antigen uptake by specific BCR usualy leads to delayed 
kinetics of antigen presentation (Lanzavecchia, 1987; 
Roosnek et al., 1988); peptide-MHC class II complexes 
are detected at the cell surface after a delay of l-3 hr. 
To determine the kinetics of antigen presentation, FcR- 
Iga- or FcR-lgp-transfected cells were incubated with IgG- 
complexed h repressorforvarious times at 37°C. The cells 
were then fixed with glutaraldehyde and incubated with the 
T cell hybridomas. FcR-lgp-transfected cells presented 
IgG-complexed antigens after a very short and unusual 
delay of 15 min and maximal stimulation was obtained 
after 30 min of incubation (Figure 4A). In the case of FcR- 
Iga-expressing cells, the 46-64 peptides were not pre- 
sented by I-A before 1 hr and a maximal stimulation was 
only obtained between 3-4 hr (Figure 4A). Similar concen- 
trationsof interleukin-2(IL-2)werefound by enzyme-linked 
immunosorbent assay (ELISA) in the supernatant of the 
T cell hybridoma activated by FcR-lga- and FcR-Igf3- 
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Figure 3. Igo and Igp Chimeras Mediate Efficient Presentation of IgG-Complexed Antigens 
Antigen presentation was assessed by culturing cells expressing FcR-lga, FcR-Igb, or FcR-IC- chimeras together with a T cell hybridoma (specific 
for the 46-64 peptide or the 12-24 peptide derived from h repressor) for 20 hr in the presence of various concentrations of )\. repressor complexed 
(closed circles) or not (open circles) with two anti-l repressor MAbs, 22D and 51F, which recognize distinct epitopes (15 tug/ml each). The release 
of IL-2 by the T cell hybridoma in the culture supernatants was determined using a CTL.LP proliferation assay. Each point represents the average 
of duplicate samples[ which varied by less than 5%. 
transfected cells, suggesting that both presenting cells 
stimulate T hybridoma cells with the same efficiency (data 
not shown) Strikingly, the Ig6-targeted antigen presenta- 
tion kinetics were faster than the kinetics described after 
antigen uptake by the BCR or Iga-targeted antigen presen- 
tation. 
To associate with MHC class II molecules, endocytosed 
antigens must be degraded to peptides in the endosomal 
pathway. The different kineticsof antigen presentation tar- 
geted by Iga and lg6 suggest that antigen is processed 
differently after internalization via these two chimeras. The 
rate of antigen degradation was therefore measured after 
Iga- and Ig6-targeted internalization. Both transfected 
cells were incubated at 37% with biotinylated h repressor 
complexed with anti-h repressor antibodies for various 
times. The amount of biotinylated antigens in cell lysates 
was measured by Western blotting with horseradish per- 
oxidase (HRP)-coupled streptavidin. The kinetics of anti- 
gen degradation were different when the immune com- 
plexes were internalized via Iga or lg6 chimeras (Figure 
48); antigen half-lives of 30 min and 2 hr were found, re- 
spectively. The same results were obtained with iodinated 
BSA coupled to DNP and complexed with IgG fraction 
purified from rabbit anti-DNP antiserum (data not shown). 
Thus, the rate of antigen degradation did not correlate 
with that of antigen presentation. Indeed, FcR-Igf3 chime- 
ras led to slow antigen degradation (Figure 48) and to rapid 
antigen presentation (Figure 4A), while FcR-lga chimeras 
had the opposite effects. Although in both cases antigens 
were degraded and peptides were bound to MHC class 
II molecules, the differences in the kineticsof antigen deg- 
radation and presentation suggest that Iga and lgf3 cyto- 
plasmic tails target antigen to different subcompartments 
of the endosomal pathway. 
Intracellular Localization of Iga- or Igp-Targeted 
Antigen and MHC Class II 
We characterized the vesicles where Iga and lgf3 chimeras 
targeted antigens using immunofluorescence and confo- 
cal microscopy. Preformed immune complexes, containing 
biotinylated X repressor and two IgGl anti-h repressor anti- 
bodies, were bound at 4% to transfected cells. The cells 
were then transferred to 37% for 30 min before fixation 
and permeabilization. To determine whether, under these 
conditions, immune complexes dissociated, internalized 
immune complexes were simultaneously revealed with 
rhodamine isothiocyanate (RITC)-coupled streptavidin 
(which recognized biotinylated h repressor) and fluores- 
cein isothiocyanate (FITC)-coupled specific goat anti- 
mouse IgGl antiserum. Before or after internalization, both 
labelings were colocalized (data not shown). After 30 min 
of incubation at 37%, biotinylated antigens were revealed 
with RITC-coupled streptavidin and early endosomes were 
labeled with FITC-coupled anti-TfR antibodies. As shown 
in Figure 5A, antigens internalized by lgf3 chimeras com- 
pletely colocalized with TfR. In the case of Iga chimeras, 
although the two markers partially colocalized, a signifi- 
cant population of antigen-containing endosomes was not 
labeled with TfR antibody. Therefore, the cytoplasmic tails 
of both Iga and lg6 determine the transport of antigens 
to early compartments of the endosomal pathway. In addi- 
tion, Iga chimeras also targeted antigen to a population of 
TfR-negative endosomes. These vesicles were not labeled 
with anti-M6P receptor antibodies (data not shown), indi- 
cating that they did not represent conventional late endo- 
somes. 
Specialized endosomal compartments were proposed 
as sites of peptide association with MHC class II in B lym- 
phocytes (Amigorena et al., 1994; West et al., 1994). To 
investigate whether the cytoplasmic tails of Iga or lgf3 se- 
lectively target antigens to an MHC class II-rich compart- 
ment, we analyzed the intracellular distribution of I-A mole- 
cules and internalized antigens by Iga and lg6 chimeras. 
When MHC class II molecules were labeled with specific 
antibodies, we typically obtained a predominant cell sur- 
face staining as well as staining of intracellular vesicles 
concentrated in the perinuclear region. This pattern varied 
from cell to cell and depended on the optical plan of section 
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Figure 4. Kinetics of Presentation and Degradation of Igu- and clgb- 
Targeted Antigens 
(A) FcR-lgu-transfected ceils (closed circles) or FcR-lgf3-transfected 
cells (open circles) were fixed with glutaraldehyde after various periods 
of incubation with IgG-complexed 5 repressor at 37%. The fixed cells 
were incubated with the T cell hybridomas (specific for the 46-64 
peptide) for 20 hr. Stimulation of T cell hybridoma was assessed by 
measuring IL-2 release in the culture supernatants using a CTL.LP 
proliferation assay. 
(B) Preformed immune complexes, containing biotinylated A repres- 
sor, were bound at 4°C on FcR-lga-expressing cells (top) or FcR- 
Igg-expressing cells (middle). After different times of incubation at 
37%, the cells were lyzed and analyzed by Western blotting with 
HRP-coupled streptavidin. Fractions of uncleaved antigens were 
quantified with a Scan densitometer (bottom). The arrows indicate 
biotinylated y repressor (Cl). 
considered. When the cells were left at 4%, the Iga chi- 
mera had a more patchy membrane distribution than the 
lgf3 chimera (Figure 5B). After 15 min of incubation at 
37%, Iga and 196 internalized immune complexes were 
localized in vesicular structures dispersed within both 
cells, distinct from the compartments containing MHC 
class II molecules. Importantly, 30 min after internalization 
of immune complexes, the pattern of immunofluorescence 
became clearly different between cells expressing Iga and 
lgf3 chimeras. In FcR-lgp-expressing cells, most of inter- 
nalized immune complexes remained dispersed within the 
cells and the staining exceptionally appeared to overlap 
with intracellular class II. In FcR-lga-transfected cells, in- 
ternalized immune complexes colocalized with MHC class 
II compartments, as evidenced by the yellow color of the 
superimposed images in the perinuclear region of the cells 
(Figure 58). The same difference of intracellular localiza- 
tion of immune complexes between the two cells was ob- 
served after 1 hr of incubation at 37% (data not shown), 
although the intensity of immune complex labeling had 
decreased. Therefore, the cytoplasmic tail of Iga targeted 
antigen to endocytic compartments where MHC class II 
molecules accumulate. In contrast, the cytoplasmic tail 
of lgp mediated antigen internalization and presentation, 
whereas it did not drive antigen to the major site of intracel- 
lular class II localization. 
A Minor Population of MHC Class II Molecules 
Is Found in Early Endosomes 
If lgp cytoplasmic tail targets immune complexes to early 
endosomes and leads to efficient antigen presentation, 
then MHC class II should be present and functional in 
early endosomes. Although the major intracellular site of 
MHC class II accumulation is distinct from classical early 
endosomes (Amigorenaet al., 1994; Qiu et al., 1994; Tulp 
et al., 1994; West et al., 1994) biochemical data from 
various groups suggested that class II molecules still have 
access to early endocytic compartments (Reid and Watts, 
1990; Salamero et al., 1990). To determine whether MHC 
class II molecules were also found in early endosomes, 
the intracellular distribution of I-A and TfR were analyzed. 
As shown in Figure 6, class II molecules and TfR partially 
colocalized. However, although the patterns of staining 
overlapped, the degree of colocalization was difficult to 
estimate. 
The major intracellular pool of MHC class II is newly 
synthesized molecules en route to the cell surface and 
should not be found in early endosomes. To determine 
whether a minor population of internalized class II mole- 
cules was nevertheless in early endosomes, the intracellu- 
lar pools of newly synthesized class II were emptied using 
the protein synthesis inhibitor cycloheximide. After 4 hr 
of cycloheximide treatment, the staining of cell surface 
class II was not affected, whereasthe labeling of intracellu- 
lar class II molecules had decreased (Figure 6). The re- 
maining intracellular class II colocalized with TfR. There- 
fore, the fraction of MHC class II that colocalizes with TfR 
is cycloheximide resistant, suggesting that it is from endo- 
cytic and not from exocytic origin. 
The presence of MHC class II in TfR-containing recycl- 
ing compartments suggested that class II might not only 
be internalized but also recycled back to the cell surface, 
together with the TfR. This possibility was first explored 
by using a 20° block, which induces the accumulation 
of internalized molecules, such as TfR, by blocking their 
recycling back to the cell surface. The weak intracellular 
labeling of class II and TfR (Figure 6) was increased after 
the cells were incubated for 30 min at 20% and the two 
markers still colocalized. These results suggest that, after 
immunity 
340 
A 
TfR 
FcFVlg-a FcWlg-p 
Figure 5. Endosomal Localization of Internalized Antigens by Iga and Igp Chimeras 
(A) Colocalization of internalized antigens with TfR. Preformed immune complexes, containing biotinylated A. repressor, were bound at 4°C on 
FcR-lga-expressing cells (left) or FcR-lgp-expressing cells (right) on glass coverslips. After 30 min of incubation at 37% the cells were fixed 
with paraformaldehyde and permeablized with saponin. TfRs were stained with FITC-coupled anti-TfR antibody (top), while biotinylated antigens 
were revealed with Texas red-coupled streptavidin (bottom). White arrows indicate the area where IgG-complexed antigens are not colocalized 
with TfR. 
(B) Colocalization of internalized antigens with MHC class II molecules. FcR-lga-expressing cells (left) or FcR-lgb-expressing cells (right) were 
incubated for 15 (middle) or 30 min (bottom) at 37% or kept on ice (top) before fixation. IgGi, contained in immune complexes, was revealed 
with FITC-coupled goat anti-mouse IgG1 antiserum, while MHC class II molecules were stained with rabbit antiserum and revealed by Texas red- 
coupled F(abqz fragments of donkey anti-rabbit IgG antiserum. Double immunofluoresence analyses were performed using a TCS4D confocal 
microscope to obtain a superimposed image of immune complexes labeling (green) and class II labeling (red). Here are shown representative 
medial optical slices. 
their transport to the cell surface, class II might be internal- 
ized and recycled back to the cell surface. 
Internalization and Recycling of MHC 
Class II Molecules 
We next tested the constitutive internalization and recy- 
cling capacities of class II molecules using cell surface 
biotinylation with cleavable NHS-SS-biotin. To measure 
internalization, FcR-lgp-transfected cells were surface 
biotinylated and incubated for different times at 37%. Half 
of the cells were then treated with glutathione to cleave 
the NHS-SS-biotin from class II molecules remaining at 
the cell surface. Total MHC class II molecules were immu- 
noprecipitated and the internalized fraction was quantified 
by Western blotting with HRP-coupled streptavidin. As 
shown in Figure 7A, the fraction of biotinylated molecules 
protected from the glutathione treatment, and therefore 
intracellular, increased during incubation time at 37%. 
The endocytosed class II reached a plateau of 15% after 
10 min of incubation. We obtained similar results with 
FcR-lgatransfected cells or untransfected cells (data not 
shown). Preincubation of the cells with immune complexes 
did not modify MHC class II internalization (data not 
shown). Thus, a fraction of cell surface MHC class II mole- 
cules are constitutively internalized. 
To be efficient for antigen presentation, internalized 
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MHC class II molecules should recycle back to the cell 
surface. This question was addressed by using a similar 
technical approach. The cells were incubated for 30 min 
at 37% and treated with glutathione, to cleave biotinylated 
class II molecules that were not intracellular at that time. 
Glutathione-treated cells were then incubated for different 
times at 37% A second glutathione treatment was per- 
formed to cleave biotin from internalized molecules that 
recycle back to the cell surface, and thus become accessi- 
ble to reduction. As shown in Figure 7B, the glutathione- 
resistant fraction of I-A molecules decreased rapidly dur- 
ing the second incubation at 37% (50% of biotinylated 
class II were reduced by gluthation after 10 min of incuba- 
tion). The cell viability was not altered by the glutathione 
treatments; the decrease of the glutathion-resistant frac- 
tion from 15% to 8% (quantitate by densitometry) after 10 
Immunity 
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Figure 6. Endosomal Localization of MHC Class II Molecules 
Endosomal localization of MHC class II molecules was determined after the emptying of intracellular pool of newly synthesized class II. II-Al .6 
cells were incubated at 37OC for 4 hr in the absence (left) or in the presence (middle and right) of 10 rg/ml cycloheximide. Before fixation and 
permeabilization. cells were incubated at 4% (middle) or at 20% (right) and cycloheximide was continuously present in the medium. TfRs were 
stained with FITC-coupled anti-TfR antibody (top), while MHC class II molecules were stained with rabbit antiserum and revealed by Texas red- 
coupled F(ab’jn fragments of donkey anti-rabbit IgG antiserum. After confocal microscopy analysis, TfR-positive compartments appeared in green 
and class II-containing compartments appeared in red. 
min therefore demonstrates the recycling of MHC class 
II molecules to the cell surface. The same results were 
obtained for I-E isoform of MHC class II (data not shown). 
These results are consistent with the possibility that cell 
surface MHC class II molecules acquire peptides after 
internalization and then recycle back to the cell surface. 
Igp-Targeted Antigen Presentation Does Not 
Require Newly Synthesized Class II 
&X-mediated antigen internalization mainly induces pre- 
sentation involving newly synthesized MHC class II mole- 
cules (Davidson et al., 1991), which reach the cell surface 
l-3 hr after their synthesis (Neefjes and Ploegh, 1992; 
Amigorenaet al., 1994). To determine whether newly syn- 
thesized class II molecules were involved in Iga- or lgp- 
targeted antigen presentation, cycloheximide was used to 
block protein synthesis. FcR-lga- or FcR-lgp-expressing 
cells were preincubated during 3 hr with cycloheximide at 
10 pglml as well as during the different times of pulse with 
IgG-complexed antigens. The cells were then fixed and 
T cell stimulation was measured as above. Inhibition of 
protein synthesis blocked antigen presentation mediated 
by Iga but not through lgb chimeras (Figure 8). The inhibi- 
tion of Iga-induced presentation was near 100% during 
the first hour of incubation with antigen, and over 90% 
after 2 hr. In contrast, no significant effect of cycloheximide 
was found when antigen presentation was measured in 
Igb-expressing cells. These results indicate that, in con- 
Vast with Iga-mediated antigen presentation, which in- 
volves newly synthesized class II, the presentation of IgG- 
complexed antigens by Igp-expressing cells did not 
require protein synthesis. Together with our morphological 
and biochemical results, the selective resistance of lgp 
antigen presentation to cycloheximide suggests that inter- 
nalized cell surface MHC class II molecules may be loaded 
with peptides and recycle back to the plasma membrane 
when antigens are internalized through IgB. 
Discussion 
A major function of B lymphocyte antigen receptors is to 
mediate the internalization of exogenous antigens and 
thus facilitate the presentation of peptide fragments by 
MHC class II molecules (Lanzavecchia, 1990). Our work 
focuses on the role of mlg-associated molecules in antigen 
internalization and processing. Our major finding demon- 
strates that the cytoplasmic domains of both Iga and lgp 
contain signals for efficient antigen internalization, but tar- 
get antigen to different functional pools of MHC class II 
molecules with different intracellular localizations. 
Involvement of BCR Subunits in Antigen 
Internalization and Presentation 
All the known internalization signals are located in the 
cytoplasmic tail of the B cell surface receptors or their 
associated subunits (Trowbridge et al., 1994). The cyto- 
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Figure 7. Internalization and Recycling of MHC Class II Molecules 
(A) Kinetics of MHC class II internalization. FcR-lgp-transfected cells 
were biotinylated with cleavable NHS-SS-biotin. After washing, the 
cells were incubated for different times at 37% and half of the cells 
were treated with glutathione before lysis. lmmunoprecipitates of I-A 
isoform of class II were analyzed by Western blotting with HRP-coupled 
streptavidin. After washing, the filter was developed using the en- 
hanced chemioluminescence Western blotting detection system (left). 
The fraction of internalized MHC class II I-A isoforms was quantified 
with a Scan densitometer (right). 
(8) Recycling of MHC class II molecules. After cell surface biotinyla- 
tion, FcR-lgp-transfected cells were incubated for 30 min at 37% and 
half of thecells were treated with glutathione. Glutathione-treated cells 
werefurtherincubatedfordifferent timesat37OCand theywere treated 
again or not with glutathione. I-A immunoprecipitates were analyzed 
by Western blotting as above. 
plasmic domains of IgM or IgD are composed of the three 
amino acids, Lys-Valine-Lys and it was therefore unlikely 
that their cytoplasmic domains could determine antigen 
internalization. Mutations in the transmembrane domain 
of IgM disrupts both the association with lgallg8 hetero- 
dimers and antigen internalization (Pate1 and Neuberger, 
1993; Shaw et al., 1990) suggesting that these associated 
chains determine immunoglobulin endocytosis. The main 
aim of the experimental approach using chimerical recep- 
tors is to study, in the same cell recipient, Iga indepen- 
dently of lg8 and independently of their association with 
mlg or other mlg-associated molecules. Our data demon- 
strate that the cytoplasmic domains of both Iga and lg8 
mediate efficient internalization of receptors via clathrin- 
coated pits. 
Consistently, we found that Iga and lg8 both enhance 
antigen presentation (at least 1 OOO-fold) when antigen was 
complexed with IgG and internalized through the chime- 
ras. This enhancement of antigen presentation is similar 
to that obtained by targeting soluble antigen on BCR (Licht- 
man et al., 1987; Lanzavecchia, 1990) or IgG-complexed 
antigen on receptors for IgG (Amigorena et al., 1992a, 
1992b; Manta et al., 1991). For both FcR and BCR, recep- 
tor-mediated endocytosis of antigens leads to the uptake 
of antigen-antibody complexes. 
Different cycloheximide sensitivities in antigen presen- 
tation assays lead us to propose that the cytoplasmic do- 
FcRhg-p -CA 
+c 
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Figure 6. Iga and clg6 Cytoplasmic Tails Target Antigens towards 
Different Pools of MHC Class II Molecules 
FcR-lga-transfected cells (left) or FcR-lg6-transfected cells (right) 
were preincubated (open circles) or not (closed circles) during 3 hr 
with cycloheximide at 10 uglml and during the different times of incuba- 
tion with IgG-complexed antigens. The fixed cells were incubated with 
the T cell hybridomas (specific for the 46-64 peptide) for 20 hr. Stimula- 
tion of T cell hybridoma was assessed by measuring IL-2 release in 
the culture supernatants using a CTL.LP proliferation assay. 
mains of Iga and lgp target antigen to different functional 
pools of MHC class II molecules. Up to now, the utilization 
of cycloheximide in antigen presentation assays did not 
allow us to understand the respective roles of preexisting 
versus newly synthesized MHC class II in antigen presen- 
tation. Some studies reported that antigen presentation 
via class II molecules was sensitive to protein synthesis 
inhibitors (Aldorini et al., 1990; Nadimi et al., 1991; St. 
Pierre and Watts, 1990), while other groups found presen- 
tation insensitive (Harding and Unanue, 1989; Nuchtern 
et al., 1990).Thesedivergentconclusions may beascribed 
to the utilization of different cell types as presenting cells, 
which may have distinct sensitivities to protein synthesis 
inhibitors, or of different antigens and T cell hybridomas. 
In our assay, the only difference is the cytoplasmic tail of 
the receptor involved in antigen internalization. The slow 
kinetics and cycloheximide sensitivity of antigen presenta- 
tion indicates that the cytoplasmic tail of Iga targets anti- 
gens to newly synthesized MHC class II molecules. This 
result accounts for the ability of mlg to target antigens 
specifically to newly synthesized class II ratherthan preex- 
isting cell surface molecules (Davidson et al., 1991). The 
delay (l-3 hr) for the detection of presented peptides after 
Iga-driven antigen internalization corresponds to the delay 
of cell surface appearance (l-3 hr) of newly synthesized 
class II (Neefjes and Ploegh, 1992). This delay is alS0 
similar to that observed by other groups, which have used 
specific mlg as receptors for antigen uptake (Lanzavec- 
chia, 1987; Roosnek et al., 1988). 
In contrast, T cell hybridoma detected peptide loading 
as early as 15 min after IgG-complexed antigen internal- 
ization via lg8 chimera. The experiments using cyclohexi- 
mide show that a preexisting pool of class II molecules 
can be used for antigen presentation in this case. The 
presentation of some virus peptides are independent of 
protein synthesis (Pinet et al., 1994), suggesting the exis- 
tence of two presentation pathways in the same cells. 
However, a major functional role for recycling class II mole- 
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cules in BCR-mediated antigen presentation was not evi- 
denced. Indeed, the association of peptides with recycling 
class II was not observed with peptides derived from inter- 
nalized antigens by BCR (Davidson, et al., 1991). Although 
one can not formally exclude that newly synthesized MHC 
class II molecules were also loaded after Igp-mediated 
internalization in the absence of cycloheximide, the close 
similarity of the kinetics of internalization and recycling of 
class II with the kinetics of Igp-targeted antigen presenta- 
tion indicated that recycling class II could be used for anti- 
gen presentation. Therefore, the cytoplasmic tail of Iga 
and lgp contain information to target antigens toward two 
different functional pools of class II molecules. 
MHC Class II and Antigen Localization 
in the Endocytic Pathway 
After reaching the cell surface, MHC class II may have 
access to the endocytic pathway by internalization, both 
associated (Roche et al., 1993) or not (Reid and Watts, 
1990; Salamero et al., 1990) with invariant chain. They 
are able, then, to recycle back to the cell surface (Reid 
and Watts, 1990; Salamero et al., 1990). In agreement 
with a rapid transit of class II through early endosomes, 
MHC class II were seen in early endosomes by cryoimmu- 
noelectron microscopy in human B-lymphoblastoid cells 
(Neefjes and Ploegh, 1992) and by cell fractionation in 
murine B cells (Castellino and Germain, 1995). Newly syn- 
thesized MHC class II molecules transiently accumulate, 
before reaching the cell surface, in endosomal-related 
compartmentscalledCllVor MIIC(Amigorenaetal., 1994; 
Pieters et al., 1991). These vesicles are a potential site 
for the association of peptide-derived antigens with class 
II molecules. 
How, then, are antigens transported to these MHC class 
II-containing endocytic compartments? It has been pre- 
viously shown that mlg targets antigen to specific class 
II compartments (West et al., 1994). We have shown that 
after internalization through the FcR-lga chimera, antigen 
and MHC class II colocalize, suggesting that, within the 
BCR, Iga mediates the transport to class II-containing 
compartments. In contrast, after Igp-driven antigen inter- 
nalization, the intracellular distribution of immune com- 
plexes remained dispersed within the cells and did not 
localize in the major site of intracellular class II accumula- 
tion. Instead, Igb-internalized antigen was found in TfR- 
positive endosomes. However, after emptying newly syn- 
thesized pool of intracellular class II by 4 hr treatment with 
cycloheximide, a minor population of intracellular MHC 
class II probably coming from the cell surface, colocalized 
with TfR. TfR-containing compartments are also stained 
by anti-class II antibodies before cycloheximide treatment, 
suggesting that newly synthesized class II also passes 
through early endosomes, as supported by recent results 
obtained by cell fractionation (Castellino and Germain, 
1995). Thus, the cytoplasmic tails of Iga and lgf3 target 
antigens to different compartments of the endosomal path- 
way where MHC class II molecules are found (Amigorena 
et al., 1994; Castellino and Germain, 1995) and may be 
loaded by antigen-derived peptides. 
The analysis of antigen processing supports these mor- 
phological data. An inverse correlation was observed be- 
tween the kinetics of antigen degradation and of antigen 
presentation. Indeed, internalization of antigen by FcR- 
lgf3 chimera leads to a slow antigen degradation (Figure 
38) but to a rapid antigen presentation (Figure 3A), while 
FcR-lga chimera has the opposite effects. The slow kinet- 
ics of degradation for lgb targeted antigen may account 
for a low proteolytic activity of the endosomal compartment 
involved. The very rapid presentation of peptides onto 
class II molecules after internalization by lg5 chimeras 
pinpoints towards endosomes with efficient recycling 
capabilities. Low proteolytic and high recycling activities 
are two functional characteristics of early endosomes 
(Trowbridge et al., 1994). In contrast, FcR-lga chimera 
drives antigen to other endocytic compartments. Thus, 
class II molecules located in early and late endocytic or- 
ganelles are selectively engaged in antigen presentation, 
depending on driving by specific targeting signals present 
in the cytoplasmic tails of Iga and lgf3. Since both Iga and 
lgf3 are internalized via clathrin-coated pits (Figure 2A), it is 
unlikely that these molecules access to recycling or newly 
synthesized class II using two different internalization path- 
ways. Although FcR-lga chimera probably pass through 
early endosomes, Iga drives antigen to other endocytic 
compartments by quickly excluding antigen from func- 
tional recycling class II. The targeting signal present in 
the cytoplasmic tail of Iga might act as the kinase activity 
of the epidermal growth factor receptor, which sorts the 
receptor toward multivesicular bodies early after its inter- 
nalization (Felder et al., 1990). Kinases of the src family, 
associating specifically with Iga cytoplasmic tail (Clark et 
al., 1992), are good candidates to explore what the cytoplas- 
mic effecters of antigen sorting in early endosomes are. 
We have shown that Iga and lgp have different intracel- 
lular antigen-targeting properties, which result in distinct 
functional antigen presentation capabilities. However, 
within the BCR, Iga and lgp are found as heterodimers 
(Campbell and Cambier, 1990; Hombach et al., 1990). 
How can the functional diversity of its two subunits account 
for the internalization and presentation properties of the 
BCR? Davidson et al. (1991) have shown that peptides 
derived from BCR-internalized antigen were mainly associ- 
ated to newly synthesized MHC class II molecules, as we 
found for Iga. However, their biochemical detection 
method is probably less sensitive than T cell activation 
assays; the association of peptides with a minor population 
of internalized class II can therefore not be excluded. lgp 
chimera allowed us to support the existence of a new anti- 
gen presentation pathway as suggested by Pinet et al. 
(1994) involving internalized class II molecules from the 
plasma membrane. A20 cells transfected with anti-DNP 
IgM presented DNP-coupled h repressor with a slow kinet- 
ics and this presentation was inhibited by cycloheximide 
(data not shown). Therefore, Iga phenotype accounts for 
the ability of wild-type BCR to target antigen to newly syn- 
thesized class II. Interestingly, cytoplasmic tail-deleted 
isoforms of Iga or lgf3 may compose the BCR during 6 
cell differentiation (Friedrich et al., 1993; lshihara et al., 
B Cell Receptor Subunits in Antigen Presentation 
345 
1993). Our results suggest that, although such hetero- 
dimer variants might all induce BCR internalization, their 
functional antigen presentation capabilities are probably 
different. Variations on the structure of specific antigen 
receptors could modulate the immune response by tar- 
geting antigen to different intracellular compartments. 
Experimental Procedures 
Chemical Reagents and Antlbodies 
NHS-SS-biotin, LC-biotin, streptavidin-HRP, -FITC, or -RITC were 
purchased from Pierce (Interchim, Paris, France). Other chemicals 
used in this study were all from Sigma (St. Louis, Missouri). RPM 1640, 
fetal calf serum (FCS), phosphate-buffered saline (PBS), penicillin, 
streptomycin, sodium pyruvate, and L-glutamine were purchased from 
GIECO (Paisley, Scotland). RPM1 depleted for methionine and cystine 
and %S hens-label were from ICN (Orsay, France). Protein A-Sepha- 
rose was from Pharmacia (Upsala, Sweden). Anti-transferrin receptor 
C2 and anti-B7 MAb were obtained from Pharmingen (San Diego, 
California). The rabbit anti-l-A antiserum reacts with the cytoplasmic 
tail of a chains (Sant et al., 1991). It was obtained from Dr. R. Germain 
(National Institutes of Health, Bethesda, Maryland). 2.462 is a rat anti- 
mouse Fc receptor MAb (Unkeless, 1979). To detect rat and rabbit 
antibodies specifically, RITC- or FlTCcoupled F(ab’)2 fragments of 
donkey antiserum were multiple labeling products obtained from Jack- 
son lmmunoreseach (West Grove, Pennsylvania). F(ab’), fragments 
of IgG fraction from a goat anti-serum specific for mouse IgGl were 
from Southern Biotechnology (Birmingham, Alabama). 
Ceil Lines and Culture Conditions 
Culturing of the T cell hybridomas and antigen presentation assays 
was performed in RPM1 1640 containing 10% FCS, 10 mM glutamine, 
penicillin (100 U/ml), streptomycin (100 mglml) and 2-ME (5 x 10m5 
M). The B iymphoma II-AI .6 is a type Ii FcyR-defective variant of A20 
B cells (Jones et al., 1966) which also does not express a chains and 
y chains of type III Fc receptors (Bonnerot et al., 1992). This cell line 
grows in RPM1 1640 containing 10% FCS, IO mM glutamine, 100 
U/ml penicillin, 100 Kg/ml streptomycin, 50 PM P-mercaptoethanol, 
and 5 mM sodium pyruvate (GIBCO, Paisley, Scotland). FcR-lga and 
FcR-Ig3 chimeras were constructed by adding the sequences encod- 
ing the putative cytoplasmic domains of iga and lg6 to the extracellular 
and transmembrane domains of cDNA encoding mouse type II Fc 
receptor for IgG (FcR). The FcR-lga and FcR-lgj3 constructs were 
stably expressed by transfection in the mouse B cell line II-Al .6. Char- 
acterization of these two transfected cell lines has been described 
elsewhere (Choquet et al., 1994). II-Al.6 cells expressing tail-minus 
FcR were described in Amigorena et al. (1992a, 1992b). Deletion of 
the cytoplasmic domain was obtained by the insertion of a stop codon 
after the first amino acid starting the cytoplasmic tail of mouse type 
II FcR for IgG. Cell surface expression of FcR was measured with the 
rat anti-mouse FcR MAb 2.4G2 and revealed by FITC-coupled mouse 
anti-rat antibodies. The samples were analyzed with a FACScan flow 
cytometer (Becton Dickinson). The CD4+ T cell hybridoma Al 26 recog- 
nizes the 46-64 peptide derived from b repressor complexed to I-Ad 
class II molecules. The CD4’ T cell hybridoma 24.4 recognizes the 
12-24 peptide derived from b repressor compfexed to I-Ad class II 
molecules (Amigorena et al., 1992a, 1992b). MHC restriction was de- 
termined by using L cells transfected with I-Ad and by inhibiting the 
recognition of 46-64/l-A complexes with the specific anti-l-Ad MAb, 
MKDG. This Tcell hybridoma was a gift of J. G. Guillet (Hopital Cochin, 
Paris, France). 
Assays for Antigen Presentation 
Antigen presentation was assessed by culturing transfected II-Al .6 
cells together with the 1 repressor-specific T cell hybridoma Al26 for 
16-20 hr in the presence of various concentrations of A. repressor 
complexed or not with two anti-repressor IgGl MAbs, 22D and 51 F, 
recognizing distinct epitopes (15 uglml each IgG) (Amigorena et al., 
1992a, 1992b). The complexes were preformed by incubating different 
concentrations of purified h repressor (from 30,000 ng to 0.5 ng), with 
15 kg/ml of each of two different purified anti-h repressor MAbs (51 F 
and22D)at37OC for 15 min.Thereleaseof IL-2 bytheTcell hybridoma 
into the culture supernatants was determined using a CTL.LP prolifera- 
tion assay (Amigorena et al., 1992a. 1992b). Each point represents the 
average of duplicate samples, which varied by less than 5%. Kinetics 
analysis was performed at a dose of antigen for which antigen presen- 
tation was strictly dependent of complex formation with the MAbs. The 
immune complexes were preformed at 37OC by mixing the purified b 
repressor (30 uglml) and 51 Fand 22D MAbs(150 pglmi each) to make 
a 10x mix in the culture medium. Preformed immune complexes (30 
~1) were added to 270 PI of presenting cells adjusted at 2.106 cells/ 
ml and incubated at 37OC for different times. The ceils were washed 
two times with PBS, fixed with 0.05% glutaraldehyde for 20 min on 
ice, then washed again two times. Fixed cells, in duplicate samples 
of 100 ul, were added to 50 pl of T cell hybridomas, adjusted to 2.106 
cells /ml. After 24 hr, IL-2 release was tested as above. Occasionally, 
presenting cells were preincubated for 3 hr at 37OC with IO pglml 
cycloheximide diluted from a stock solution at 10 mglml in water. In 
this case, cycloheximide was also present during the incubation with 
preformed immune complexes up to fixation with glutaraldehyde. 
Assay for Antigen Degradation 
The kinetics of antigen degradation was determined by quantitating 
biotinylated antigens after different times of internalization via Iga and 
196, chimeras. FcR-lga- and FcR-lgp-transfected cells were washed 
two times with cold PBS and they were incubated for 3 hr on ice with 
preformed immune complexes (biotinylated I. repressor, 3 pglml; 51F 
and 22D MAbs, 15 &ml each) in PBS containing 5 mM sodium pyru- 
vate, 1% glucose, 1% BSA. In these conditions, both cells bind similar 
amounts of immune complexes revealed with FITC-coupled streptavi- 
din as measured by FACScan analysis (data not shown). The antigen 
binding on the cells was mediated by Fc receptor portion of the chi- 
mera, since first, the binding of immune complexes was completely 
inhibited by preincubating the cells with the anti-FcR MAb 2.4G2, and 
second, binding of biotinylated antigen was dependent on complex 
formation with anti-h repressor antibodies (data not shown). After ex- 
tensive washing with cold PBS, 2.106 cells were dispensed in eppen- 
dorf tubes and internalization was started with prewarmed culture me- 
dia, then incubated for different times at 37OC. The cells were then 
transferred on ice and washed with cold PBS, cellular pellets were 
lysed with 1% Triton X-100,20 mM Tris-HCI (pH 6.0) 150 mM NaCI, 
5 mM EDTA, and 0.1% BSA. Postnuclear supernatants were boiled 
in 40 ml of Laemmli’s buffer, then resolved under reducing conditions 
by SDS-PAGE in 12% polyacrylamide gels and transterred onto PVDF 
membranes (Mlllipore). The membrane was probed with streptavidin 
conjugated to peroxidase at 2 &ml in 20 mM Tris-HCI (pH 6.0) con- 
taining 150 mM NaCI, 5% low fat milk and 0.05 % Tween 20. After 
four washes, the filter was developed using the enhanced chemiolu- 
minescence Western blotting detection system (Amersham, Les Ulis. 
France). The antigen was quantified with a Scan densitometer. To 
ensure that immune complexes were not released during incubation 
at 37OC, the cellular supernatants were adsorbed on protein A-Sepha- 
rose. After washing of the immunoadsorbents, the samples were ana- 
lyzed in the same conditions. No antigen was detected in the superna- 
tants, showing that most of the antigens that were bound on the cells, 
via immune complexes, were internalized (data not shown). 
Assay for Endocytosis of YHC Class Ii Molecules 
The detection of internalization of cell surface MHC class II was per- 
formed after cell surface biotinylation. Cells (4 x 10’) were cell surface 
biotinylated with a solution containing 3.75 mg of NHS-SS-biotin in 
3 ml of cold PBS for 5 min at 4OC. Cells were then washed extensively 
in cold PBS and residual active groups were quenched with PBS con- 
taining 50 mM NH&I for 20 min at 4°C. Cells were incubated for 3 
hr on ice with preformed immune complexes (A repressor, 3 kg/ml ; 
51F and 22D MAbs, 15 uglml each) in PBS containing 5 mM sodium 
pyruvate, 1% glucose, 1% BSA. Cells were washed then dispensed 
in eppendorf tubes. Internalization was started with prewarmed culture 
media, then incubated at 37OC for different times. After washing in 
cold PBS, biotin remaining at the cell surface was or was not stripped 
with 1 ml of a solution containing 1.55 mg of glutathione, 150 mM 
NaCI, 10% FCS, and 5 ml of 50% NaOH for 30 min on ice. Cells were 
Immunity 
346 
washed then lysed with 1% Triton X-100, 20 mM Tris-HCI (pH 8.0) 
150 mM NaCI, 5 mM EDTA, and 0.1% BSA. Postuclear supernatants 
were adsorbed on protein A-Sepharose then immunoprecipitated with 
precoated immunoadsorbents. They were prepared by incubating pro- 
tein A-Sepharose (50 nl in lysis buffer)) with a rabbit anti I-A antiserum 
(1 nl) generated against a peptide corresponding to the cytoplasmic 
tail of the I-A a chain (Sant et al., 1991). After immunoprecipitation 
and washing of the immunoadsorbents, the samples were boiled in 
40 ~1 of Laemmli’s buffer resolved under nonreducing conditions by 
SDS-PAGE in 12% polyacrylamide gels and transferred onto PVDF 
membranes (Mlllipore). The membrane was probed with streptavidin 
conjugated to peroxidase as above. To look for MHC class II recycling, 
the protocol was essentially the same. Biotinylated cells were incu- 
bated at 37OC for 30 min, then treated with glutathione. After this first 
treatment, cells were incubated for different times at 37OC, then they 
were treated or not with gluthatione. Lysates were immunoprecipitated 
and analyzed as above. Y-24G2 MAb uptake was performed essen- 
tially as previously described (Bonnerot and Daeron, 1994). 
lmmunofluorescence Staining and Confocal Microscopy 
Cells were washed twice in cold PBS, then were allowed to adhere, 
on ice, on glasscoverslips precoated with a 0.2% poly-L-lysine solution 
in water. Cells were incubated for 3 hr on ice with preformed immune 
complexes in which the A repressor was biotinylated with LC-biotin 
(1 repressor, 3 Hglml; 51F and 22D IgGl MAb, 15 pg/ml each) in PBS 
containing 5 mM sodium pyruvate, 1% glucose, 1% BSA. Cells were 
washed, then internalization was started with prewarmed culture me- 
dia, then incubated at 37°C for different times. Cells were fixed in 3% 
paraformaldehyde for 10 min at room temperature. After permeabiliza- 
tion with 0.05% saponin in PBS supplemented with 0.2% BSA. they 
were incubated with specific antibodies. The immune complexes were 
labeled either with FITC- or RITC-coupled streptavidin (10 pglml in 
PBS, 0.2% BSA, 0.05% saponin) to detect biotinylated antigens or 
with FITC- or RITC-coupled F(ab’), fragment of specific goat anti- 
mouse IgGl (10 ug/ml in PBS, 0.2% BSA, 0.05% saponin), which 
recognize the antibodies of the immune complexes. Before or after 
internalization, immune complexes were always colabeled by strepta- 
vidin and anti-IgGl antiserum. The FIT&coupled rat anti mouse TfR 
MAb C2 (Pharmingen, San Diego, California) was used at 10 pglml 
in PBS, 0.2% BSA, 0.05% saponin. MHC class II molecules were 
detected with l/l00 dilution of a rabbit anti-l-8 antiserum specific for 
the cytoplasmic tail of a chains (Sant et al., 1991). After three succes- 
sive washes, the cells were then stained with F(ab’) 2 fragments of 
RITC-coupled donkey anti-rabbit IgG antiserum. The coverslips were 
then mounted in Mowiol. Confocal laser scanning microscopy and 
double immunofluorescence analysis were performed using a Leica 
TCS microscope essentially as previously described (Amigorena et 
al., 1992b). 
Electron Microscopy 
Cells were cooled on ice for 15 min and then incubated with 24G2 
MAb directly coupled to 12 nm gold particles for 30 min at 4OC. Internal- 
ization was initiated by adding prewarmed F(ab)n fragments of mouse 
anti-rat antiserum diluted at 30 pglml in culture medium. Cells were 
incubated for 10 min at 37OC, then fixed with an equal volume of 
prewarmed 3% glutaraldehyde for 10 min. Cells were then fixed essen- 
tially as already described (Gachet et al., 1992). In brief, an equal 
volume of cold 1.5% glutaraldehyde in 0.1 M sodium cacodylate buffer 
containing 1% sucrose (pH 7.3)was added on cells for a 1 hr incubation 
on ice. Cells were then prepared for transmission electron microscopy 
as previously published (Gachet et al., 1992). Gold-labeled antibodies 
were prepared as described (Hanau et al., 1991). 
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